Atlas Trials

Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors

Clinical trial NCT02161692 · COMPLETED

Trial details

NCT number
NCT02161692
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Testicular NeoplasmsGerm Cell Tumors
Start date
1996-12-01
Primary completion
2007-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.